CERILIEN LAMY: Open Payments
NPI 1124493689 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$829 in 37 payments from 13 companies in 2025. Trend: 2023 $770 · 2024 $623 · 2025 $829
Food & beverage: $819Education: $11
| Company | Payments | Amount |
|---|---|---|
| Averitas Pharma Inc. | 6 | $207 |
| Insmed, Inc. | 11 | $201 |
| Merck Sharp & Dohme LLC | 6 | $141 |
| Reprise Biomedical, Inc. | 2 | $43 |
| ABBVIE INC. | 2 | $42 |
| Shionogi Inc | 2 | $40 |
| Tactile Systems Technology Inc | 1 | $30 |
| Paratek Pharmaceuticals, Inc. | 2 | $29 |
| Theratechnologies Inc. | 1 | $27 |
| ViiV Healthcare Company | 1 | $21 |
Products named: QUTENZA, Arikayce, ZERBAXA, PIFELTRO, Miro3D, MAVYRET, Fetroja, Flexitouch Plus.
Industry payments across FL — which companies pay providers there.
